Back to search results

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

Abroad (travel likely)RecruitingPHASE3

Conditions

Pancreas Cancer · Oligometastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cooper Hospital University Medical Center, Camden, New Jersey, United States

    Contact: Study coordinator (Megan Mezera, MD) · mezera-megan@cooperhealth.edu
    Contact: Principal Investigator (Megan Mezera, MD)

  • Cooper Hospital University Medical Center, Voorhees Township, New Jersey, United States

    Contact: Study coordinator (Megan Mezera, MD) · mezera-megan@cooperhealth.edu
    Contact: Principal Investigator (Megan Mezera, MD)

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ethan Ludmir, MD) · ebludmir@mdanderson.org · 713-825-3169
    Contact: Principal Investigator (Ethan Ludmir, MD)
Study leads

  • Ethan Ludmir, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)